{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T05:55:22Z","timestamp":1781762122737,"version":"3.54.5"},"reference-count":107,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T00:00:00Z","timestamp":1781740800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001321","name":"National Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001321","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003625","name":"Ministry of Health and Welfare","doi-asserted-by":"publisher","award":["RS-2025-02303821"],"award-info":[{"award-number":["RS-2025-02303821"]}],"id":[{"id":"10.13039\/501100003625","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Glioblastoma (GBM) remains one of the most lethal and treatment-refractory brain tumors, characterized by rapid recurrence and profound resistance to conventional therapies. The mechanisms underlying GBM resilience converge on two interdependent axes: intratumoral heterogeneity and adaptive tumor microenvironment (TME) remodeling, which engage in reciprocal crosstalk to promote immune evasion, invasion, and tumor persistence. Epigenetic regulation has emerged as a central determinant of tumor plasticity and cellular adaptability within this context. Methyl-CpG-binding domain protein 3 (MBD3), a core structural and regulatory component of the NuRD complex, represents a functionally distinctive epigenetic regulator that operates beyond canonical methylation-dependent pathways. With well-established roles in lineage commitment and neural development, MBD3 has been increasingly implicated in GBM progression, glioma stem cell maintenance, and therapeutic resistance. In parallel, GBM actively co-opts non-neoplastic TME components - including microglia, the resident innate immune sentinels of the central nervous system - which exert context-dependent tumor-supportive and tumor-suppressive functions. Understanding how MBD3 shapes tumor\u2013immune interactions and modulates innate immune regulation is therefore of growing biological and translational importance. This review provides an overview of the MBD protein family and delineates the multifaceted roles of MBD3 in developmental and GBM biology, with particular emphasis on tumor-intrinsic heterogeneity and TME remodeling. By integrating epigenetic, cellular, and immunological perspectives, we highlight emerging evidence linking MBD3 to tumor plasticity and immune modulation, and propose hypothetical regulatory frameworks that warrant experimental investigation. Clarifying the context-dependent functions of MBD3 may yield mechanistic insights into GBM pathogenesis and inform the development of novel epigenetic therapeutic strategies.<\/jats:p>","DOI":"10.3389\/fimmu.2026.1830872","type":"journal-article","created":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T05:34:34Z","timestamp":1781760874000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Bridging MBD3 functions in developmental biology and glioma heterogeneity to immune remodeling with future perspectives"],"prefix":"10.3389","volume":"17","author":[{"given":"Nhu Thi Quynh","family":"Mai","sequence":"first","affiliation":[{"name":"Department of Medical Biotechnology, Yeungnam University","place":["Gyeongsan, Republic of Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Byoung-San","family":"Moon","sequence":"additional","affiliation":[{"name":"Department of Medical Biotechnology, Yeungnam University","place":["Gyeongsan, Republic of Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,6,18]]},"reference":[{"key":"B1","volume-title":"Central nervous system tumours world health organization classification of tumours","year":"2021"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.cd011773","article-title":"Procarbazine, lomustine and vincristine for recurrent high\u2010grade glioma","volume":"7","author":"Parasramka","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1007\/s11060-017-2736-x","article-title":"Toxicity and efficacy of lomustine and bevacizumab in recurrent glioblastoma patients","volume":"137","author":"Jakobsen","year":"2018","journal-title":"J Neuro-Oncol"},{"key":"B4","first-page":"197","article-title":"Current standards of care in glioblastoma therapy","volume-title":"Exon publ","author":"Fernandes","year":"2017"},{"key":"B5","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.rpor.2018.09.003","article-title":"Survival after radiation therapy for high-grade glioma","volume":"24","author":"Marra","year":"2019","journal-title":"Rep Pract Oncol Radiother"},{"key":"B6","doi-asserted-by":"publisher","first-page":"36631","DOI":"10.18632\/oncotarget.26344","article-title":"Tumour treating fields in a combinational therapeutic approach","volume":"9","author":"Branter","year":"2018","journal-title":"Oncotarget"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.3390\/cancers11020174","article-title":"Treatment of glioblastoma (GBM) with the addition of tumor-treating fields (TTF): a review","volume":"11","author":"Fabian","year":"2019","journal-title":"Cancers"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.3390\/molecules26041169","article-title":"Challenges and perspectives of standard therapy and drug development in high-grade gliomas","volume":"26","author":"Chelliah","year":"2021","journal-title":"Molecules"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/noy032","article-title":"CAR T-cell therapy for glioblastoma: recent clinical advances and future challenges","volume":"20","author":"Bagley","year":"2018","journal-title":"Neuro-Oncol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1093\/neuros\/nyaa584","article-title":"Chimeric antigen receptor T-cell therapy: updates in glioblastoma treatment","volume":"88","author":"Feldman","year":"2021","journal-title":"Neurosurgery"},{"key":"B11","doi-asserted-by":"publisher","first-page":"vi1","DOI":"10.1093\/neuonc\/noae145","article-title":"CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2017\u20132021","volume":"26","author":"Price","year":"2024","journal-title":"Neuro-Oncol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1038\/s41588-024-01880-x","article-title":"Epigenetic therapy potentiates transposable element transcription to create tumor-enriched antigens in glioblastoma cells","volume":"56","author":"Jang","year":"2024","journal-title":"Nat Genet"},{"key":"B13","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1007\/s12032-025-02760-y","article-title":"Epigenetic reprogramming and antitumor immune responses in gliomas: a systematic review","volume":"42","author":"Riyas Mohamed","year":"2025","journal-title":"Med Oncol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"12","DOI":"10.20517\/cdr.2024.157","article-title":"The epigenetic mechanisms involved in the treatment resistance of glioblastoma","volume":"8","author":"Shahani","year":"2025","journal-title":"Cancer Drug Resist"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/j.stem.2016.11.003","article-title":"Adaptive chromatin remodeling drives glioblastoma stem cell plasticity and drug tolerance","volume":"20","author":"Liau","year":"2017","journal-title":"Cell Stem Cell"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.13173","article-title":"Regulatory landscape and clinical implication of MBD3 in human Malignant glioma","volume":"7","author":"Cui","year":"2016","journal-title":"Oncotarget"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20191340","article-title":"Glioma stem-like cells evade interferon suppression through MBD3\/NuRD complex\u2013mediated STAT1 downregulation","volume":"217","author":"Zhan","year":"2020","journal-title":"J Exp Med"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1172\/jci127916","article-title":"Epigenetic modulator inhibition overcomes temozolomide chemoresistance and antagonizes tumor recurrence of glioblastoma","volume":"130","author":"Moon","year":"2020","journal-title":"J Clin Invest"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.stem.2014.04.019","article-title":"MBD3\/NuRD facilitates induction of pluripotency in a context-dependent manner","volume":"15","author":"Dos Santos","year":"2014","journal-title":"Cell Stem Cell"},{"key":"B20","first-page":"8147","article-title":"Methyl-CpG-binding domain 3 (Mbd3) is an important regulator for apoptosis in mouse embryonic stem cells","volume":"12","author":"Dai","year":"2020","journal-title":"Am J Transl Res"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.2001220","article-title":"Smek promotes corticogenesis through regulating Mbd3\u2019s stability and Mbd3\/NuRD complex recruitment to genes associated with neurogenesis","volume":"15","author":"Moon","year":"2017","journal-title":"PloS Biol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s12276-025-01510-4","article-title":"Canonical Wnt signaling regulates Mbd3 protein stability during neurogenesis","volume":"57","author":"Mai","year":"2025","journal-title":"Exp Mol Med"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.603495","article-title":"The role of microglia in glioblastoma","volume":"10","author":"Geribaldi-Dold\u00e1n","year":"2021","journal-title":"Front Oncol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1242\/dev.02802","article-title":"Mbd3, a component of the NuRD co-repressor complex, is required for development of pluripotent cells","volume":"134","author":"Kaji","year":"2007","journal-title":"Dev Camb Engl"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1242\/jcs.03099","article-title":"MBD family proteins: reading the epigenetic code","volume":"119","author":"Fatemi","year":"2006","journal-title":"J Cell Sci"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1038\/nrg2341","article-title":"DNA methylation landscapes: provocative insights from epigenomics","volume":"9","author":"Suzuki","year":"2008","journal-title":"Nat Rev Genet"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1007\/s00412-009-0221-9","article-title":"DNA methylation and methyl-CpG binding proteins: developmental requirements and function","volume":"118","author":"Bogdanovi\u0107","year":"2009","journal-title":"Chromosoma"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.3390\/ijms16035125","article-title":"An epigenetic regulator: methyl-CpG-binding domain protein 1 (MBD1)","volume":"16","author":"Li","year":"2015","journal-title":"Int J Mol Sci"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkv168","article-title":"An intrinsically disordered region of methyl-CpG binding domain protein 2 (MBD2) recruits the histone deacetylase core of the NuRD complex","volume":"43","author":"Desai","year":"2015","journal-title":"Nucleic Acids Res"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1038\/45843","article-title":"The thymine glycosylase MBD4 can bind to the product of deamination at methylated CpG sites","volume":"401","author":"Hendrich","year":"1999","journal-title":"Nature"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/j.dnarep.2019.102687","article-title":"Modification of the base excision repair enzyme MBD4 by the small ubiquitin-like molecule SUMO1","volume":"82","author":"Sannai","year":"2019","journal-title":"DNA Repair"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmb.2021.167097","article-title":"Structural insights into the mechanism of base excision by MBD4","volume":"433","author":"Pidugu","year":"2021","journal-title":"J Mol Biol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M203455200","article-title":"The mCpG-binding domain of human MBD3 does not bind to mCpG but interacts with NuRD\/Mi2 components HDAC1 and MTA2","volume":"277","author":"Saito","year":"2002","journal-title":"J Biol Chem"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2011.11.054","article-title":"Mbd3\/NURD complex regulates expression of 5-hydroxymethylcytosine marked genes in embryonic stem cells","volume":"147","author":"Yildirim","year":"2011","journal-title":"Cell"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkv098","article-title":"Dissecting the behavior and function of MBD3 in DNA methylation homeostasis by single-molecule spectroscopy and microscopy","volume":"43","author":"Cui","year":"2015","journal-title":"Nucleic Acids Res"},{"key":"B36","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1038\/nature12587","article-title":"Deterministic direct reprogramming of somatic cells to pluripotency","volume":"502","author":"Rais","year":"2013","journal-title":"Nature"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1002\/neu.10199","article-title":"Differential expression of methyl CpG\u2010binding domain containing factor MBD3 in the developing and adult rat brain","volume":"55","author":"Jung","year":"2003","journal-title":"J Neurobiol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1004028","article-title":"MBD3 localizes at promoters, gene bodies and enhancers of active genes","volume":"9","author":"Shimbo","year":"2013","journal-title":"PloS Genet"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1128\/mcb.01880-06","article-title":"Epigenetic programming of the rRNA promoter by MBD3","volume":"27","author":"Brown","year":"2007","journal-title":"Mol Cell Biol"},{"key":"B40","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.gene.2008.05.009","article-title":"DNA demethylation induced by the methyl-CpG-binding domain protein MBD3","volume":"420","author":"Brown","year":"2008","journal-title":"Gene"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1128\/mcb.00467-08","article-title":"MBD3, a component of the NuRD complex, facilitates chromatin alteration and deposition of epigenetic marks","volume":"28","author":"Morey","year":"2008","journal-title":"Mol Cell Biol"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1101\/2020.07.27.223438","article-title":"Polycomb-mediated genome architecture enables long-range spreading of H3K27 methylation","volume":"119","author":"Kraft","year":"2022","journal-title":"Proc Natl Acad Sci"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1002\/stem.2046","article-title":"Ctbp2 modulates NuRD-mediated deacetylation of H3K27 and facilitates PRC2-mediated H3K27me3 in active embryonic stem cell genes during exit from pluripotency","volume":"33","author":"Kim","year":"2015","journal-title":"Stem Cells"},{"key":"B44","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1038\/emboj.2011.431","article-title":"NuRD-mediated deacetylation of H3K27 facilitates recruitment of Polycomb Repressive Complex 2 to direct gene repression","volume":"31","author":"Reynolds","year":"2011","journal-title":"EMBO J"},{"key":"B45","doi-asserted-by":"publisher","first-page":"27204","DOI":"10.1038\/s41598-025-12427-3","article-title":"Interaction and regulatory expression of Polycomb and NuRD complexes in mouse embryonic stem cell under PKC inhibition","volume":"15","author":"Wu","year":"2025","journal-title":"Sci Rep"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1038\/s44318-024-00111-7","article-title":"The GATAD2B-NuRD complex drives DNA: RNA hybrid-dependent chromatin boundary formation upon DNA damage","volume":"43","author":"Liu","year":"2024","journal-title":"EMBO J"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2019.06.024","article-title":"An integrative model of cellular states, plasticity, and genetics for glioblastoma","volume":"178","author":"Neftel","year":"2019","journal-title":"Cell"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1200\/jco.2016.66.6552","article-title":"Immune checkpoint inhibition for hypermutant glioblastoma multiforme resulting from germline biallelic mismatch repair deficiency","volume":"34","author":"Bouffet","year":"2016","journal-title":"J Clin Oncol"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.615400","article-title":"Genetic architectures and cell-of-origin in glioblastoma","volume":"10","author":"Kim","year":"2021","journal-title":"Front Oncol"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2017.01.018","article-title":"Clonal heterogeneity and tumor evolution: past, present, and the future","volume":"168","author":"McGranahan","year":"2017","journal-title":"Cell"},{"key":"B51","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13059-020-02085-1","article-title":"Single-cell lineage analysis reveals genetic and epigenetic interplay in glioblastoma drug resistance","volume":"21","author":"Eyler","year":"2020","journal-title":"Genome Biol"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.51335\/organoid.2022.2.e8","article-title":"Fundamental signaling pathways for glioblastoma drug resistance and developing robust organoid models for drug discovery","volume":"2","author":"Pratap","year":"2022","journal-title":"Organoid"},{"key":"B53","unstructured":"Expression of MBD3 in glioma - The Human Protein Atlas"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2014.00046","article-title":"Diversity of two forms of DNA methylation in the brain","volume":"5","author":"Chen","year":"2014","journal-title":"Front Genet"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1038\/nature10866","article-title":"IDH1 mutation is sufficient to establish the glioma hypermethylator phenotype","volume":"483","author":"Turcan","year":"2012","journal-title":"Nature"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2010.03.017","article-title":"Identification of a CpG island methylator phenotype that defines a distinct subgroup of glioma","volume":"17","author":"Noushmehr","year":"2010","journal-title":"Cancer Cell"},{"key":"B57","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.ccr.2010.12.014","article-title":"Oncometabolite 2-hydroxyglutarate is a competitive inhibitor of \u03b1-ketoglutarate-dependent dioxygenases","volume":"19","author":"Xu","year":"2011","journal-title":"Cancer Cell"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/noab106","article-title":"The 2021 WHO classification of tumors of the central nervous system: a summary","volume":"23","author":"Louis","year":"2021","journal-title":"Neuro-Oncol"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1038\/nature16490","article-title":"Insulator dysfunction and oncogene activation in IDH mutant gliomas","volume":"529","author":"Flavahan","year":"2016","journal-title":"Nature"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms13177","article-title":"5-Hydroxymethylcytosine localizes to enhancer elements and is associated with survival in glioblastoma patients","volume":"7","author":"Johnson","year":"2016","journal-title":"Nat Commun"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1007\/s00401-018-1821-3","article-title":"5-Hydroxymethylcytosine preferentially targets genes upregulated in isocitrate dehydrogenase 1 mutant high-grade glioma","volume":"135","author":"Glowacka","year":"2018","journal-title":"Acta Neuropathol (Berl)"},{"key":"B62","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1007\/978-94-007-7744-6_11-1","article-title":"LGR5 is a marker of poor prognosis in glioblastoma and is required for survival of brain cancer stem\u2010like cells","volume":"23","author":"Nakata","year":"2013","journal-title":"Brain Pathol"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.3892\/or.2013.2826","article-title":"Knockdown of LGR5 suppresses the proliferation of glioma cells in vitro and in vivo","volume":"31","author":"Wang","year":"2014","journal-title":"Oncol Rep"},{"key":"B64","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.3727\/096504017x14874323871217","article-title":"Overexpression of MicroRNA-216a suppresses proliferation, migration, and invasion of glioma cells by targeting leucine-rich repeat-containing G protein-coupled receptor 5","volume":"25","author":"Zhang","year":"2017","journal-title":"Oncol Res"},{"key":"B65","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.1038\/s41467-019-09853-z","article-title":"Stem cell-associated heterogeneity in Glioblastoma results from intrinsic tumor plasticity shaped by the microenvironment","volume":"10","author":"Dirkse","year":"2019","journal-title":"Nat Commun"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1016\/j.stem.2014.01.005","article-title":"Osteopontin-CD44 signaling in the glioma perivascular niche enhances cancer stem cell phenotypes and promotes aggressive tumor growth","volume":"14","author":"Pietras","year":"2014","journal-title":"Cell Stem Cell"},{"key":"B67","doi-asserted-by":"publisher","first-page":"6267","DOI":"10.18632\/oncotarget.3365","article-title":"Coexpression analysis of CD133 and CD44 identifies proneural and mesenchymal subtypes of glioblastoma multiforme","volume":"6","author":"Brown","year":"2015","journal-title":"Oncotarget"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0172791","article-title":"Expression of CD133 and CD44 in glioblastoma stem cells correlates with cell proliferation, phenotype stability and intra-tumor heterogeneity","volume":"12","author":"Brown","year":"2017","journal-title":"PloS One"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/5387041","article-title":"Significance of glioma stem\u2010like cells in the tumor periphery that express high levels of CD44 in tumor invasion, early progression, and poor prognosis in glioblastoma","volume":"2018","author":"Nishikawa","year":"2018","journal-title":"Stem Cells Int"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.3892\/ijo.2016.3354","article-title":"Differential expression of CXCR4 and CXCR7 with various stem cell markers in paired human primary and recurrent glioblastomas","volume":"48","author":"FL\u00fch","year":"2016","journal-title":"Int J Oncol"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.1005069","article-title":"The complex interactions between the cellular and non-cellular components of the brain tumor microenvironmental landscape and their therapeutic implications","volume":"12","author":"Faisal","year":"2022","journal-title":"Front Oncol"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1186\/1476-4598-12-74","article-title":"Role of moesin in hyaluronan induced cell migration in glioblastoma multiforme","volume":"12","author":"DeSouza","year":"2013","journal-title":"Mol Cancer"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.3389\/fmats.2018.00039","article-title":"Influence of hyaluronic acid transitions in tumor microenvironment on glioblastoma Malignancy and invasive behavior","volume":"5","author":"Chen","year":"2018","journal-title":"Front Mater"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1002\/adtp.202400041","article-title":"Targeting glioblastoma tumor hyaluronan to enhance therapeutic interventions that regulate metabolic cell properties","volume":"7","author":"Neves","year":"2024","journal-title":"Adv Ther"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.ccr-15-2888","article-title":"Survival and proliferation of neural progenitor\u2013derived glioblastomas under hypoxic stress is controlled by a Cxcl12\/Cxcr4 autocrine-positive feedback mechanism","volume":"23","author":"Calinescu","year":"2017","journal-title":"Clin Cancer Res"},{"key":"B76","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1186\/s13046-019-1319-4","article-title":"Notch1 signaling pathway promotes invasion, self-renewal and growth of glioma initiating cells via modulating chemokine system CXCL12\/CXCR4","volume":"38","author":"Yi","year":"2019","journal-title":"J Exp Clin Cancer Res"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0073426","article-title":"Functional cross talk between CXCR4 and PDGFR on glioblastoma cells is essential for migration","volume":"8","author":"Sciaccaluga","year":"2013","journal-title":"PloS One"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1159\/000533130","article-title":"ABCF1\/CXCL12\/CXCR4 enhances glioblastoma cell proliferation, migration, and invasion by activating the PI3K\/AKT signal pathway","volume":"46","author":"Yin","year":"2024","journal-title":"Dev Neurosci"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1186\/1475-2867-13-85","article-title":"Disrupting the CXCL12\/CXCR4 axis disturbs the characteristics of glioblastoma stem-like cells of rat RG2 glioblastoma","volume":"13","author":"Lee","year":"2013","journal-title":"Cancer Cell Int"},{"key":"B80","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1172\/jci40283","article-title":"Inhibition of vasculogenesis, but not angiogenesis, prevents the recurrence of glioblastoma after irradiation in mice","volume":"120","author":"Kioi","year":"2010","journal-title":"J Clin Invest"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.34329","article-title":"CXCR4 expression is associated with proneural\u2010to\u2010mesenchymal transition in glioblastoma","volume":"152","author":"Khan","year":"2023","journal-title":"Int J Cancer"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1039\/c6ib00167j","article-title":"Interstitial flow differentially increases patient-derived glioblastoma stem cell invasion via CXCR4, CXCL12, and CD44-mediated mechanisms","volume":"8","author":"Kingsmore","year":"2016","journal-title":"Integr Biol"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1217002110","article-title":"Activation of PI3K\/Akt pathway by CD133-p85 interaction promotes tumorigenic capacity of glioma stem cells","volume":"110","author":"Wei","year":"2013","journal-title":"Proc Natl Acad Sci"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1038\/s41388-019-1086-x","article-title":"A CD133-AKT-Wnt signaling axis drives glioblastoma brain tumor-initiating cells","volume":"39","author":"Manoranjan","year":"2020","journal-title":"Oncogene"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.642719","article-title":"Could we address the interplay between CD133, Wnt\/\u03b2-catenin, and TERT signaling pathways as a potential target for glioblastoma therapy","volume":"11","author":"Behrooz","year":"2021","journal-title":"Front Oncol"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1038\/s41418-022-00969-2","article-title":"Hypoxia-induced GLT8D1 promotes glioma stem cell maintenance by inhibiting CD133 degradation through N-linked glycosylation","volume":"29","author":"Liu","year":"2022","journal-title":"Cell Death Differ"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1038\/onc.2009.252","article-title":"Hypoxia promotes expansion of the CD133-positive glioma stem cells through activation of HIF-1\u03b1","volume":"28","author":"Soeda","year":"2009","journal-title":"Oncogene"},{"key":"B88","doi-asserted-by":"publisher","first-page":"76238","DOI":"10.18632\/oncotarget.12803","article-title":"Resistance of glioma cells to nutrient-deprived microenvironment can be enhanced by CD133-mediated autophagy","volume":"7","author":"Sun","year":"2016","journal-title":"Oncotarget"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1007\/s13402-018-0374-8","article-title":"A HIF-independent, CD133-mediated mechanism of cisplatin resistance in glioblastoma cells","volume":"41","author":"Ahmed","year":"2018","journal-title":"Cell Oncol"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.14348\/molcells.2017.0089","article-title":"CD133 regulates IL-1\u03b2 signaling and neutrophil recruitment in glioblastoma","volume":"40","author":"Lee","year":"2017","journal-title":"Mol Cells"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.29379","article-title":"Resident microglia, and not peripheral macrophages, are the main source of brain tumor mononuclear cells","volume":"137","author":"M\u00fcller","year":"2015","journal-title":"Int J Cancer"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.15252\/embj.2019103790","article-title":"Microglia promote glioblastoma via mTOR\u2010mediated immunosuppression of the tumour microenvironment","volume":"39","author":"Dumas","year":"2020","journal-title":"EMBO J"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1007\/s00401-015-1529-6","article-title":"Resident microglia rather than peripheral macrophages promote vascularization in brain tumors and are source of alternative pro-angiogenic factors","volume":"131","author":"Brandenburg","year":"2016","journal-title":"Acta Neuropathol (Berl)"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1002\/glia.21022","article-title":"Microglia promote colonization of brain tissue by breast cancer cells in a Wnt\u2010dependent way","volume":"58","author":"Pukrop","year":"2010","journal-title":"Glia"},{"key":"B95","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.molmed.2018.11.004","article-title":"Transcriptional and epigenetic regulation of microglia in health and disease","volume":"25","author":"Yeh","year":"2019","journal-title":"Trends Mol Med"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2022.1072046","article-title":"Transcriptional and epigenetic regulation of microglia in maintenance of brain homeostasis and neurodegeneration","volume":"15","author":"Maurya","year":"2023","journal-title":"Front Mol Neurosci"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1111\/imr.13317","article-title":"Epigenetic control of microglial immune responses","volume":"323","author":"Scholz","year":"2024","journal-title":"Immunol Rev"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1052925","article-title":"Microglial immune regulation by epigenetic reprogramming through histone H3K27 acetylation in neuroinflammation","volume":"14","author":"Huang","year":"2023","journal-title":"Front Immunol"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1038\/srep33736","article-title":"MBD3 expression and DNA binding patterns are altered in a rat model of temporal lobe epilepsy","volume":"6","author":"Bednarczyk","year":"2016","journal-title":"Sci Rep"},{"key":"B100","unstructured":"Single cell type - MBD3 - The Human Protein Atlas"},{"key":"B101","unstructured":"Brain tissue expression of MBD3 - Summary - The Human Protein Atlas"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2024.114908","article-title":"Deep proteomic analysis of microglia reveals fundamental biological differences between model systems","volume":"43","author":"Lloyd","year":"2024","journal-title":"Cell Rep"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1007\/s12035-018-1150-5","article-title":"GBM-derived Wnt3a induces M2-like phenotype in microglial cells through Wnt\/\u03b2-catenin signaling","volume":"56","author":"Matias","year":"2019","journal-title":"Mol Neurobiol"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1093\/jnen\/nlw016","article-title":"Glioma stem cells but not bulk glioma cells upregulate IL-6 secretion in microglia\/brain macrophages via toll-like receptor 4 signaling","volume":"75","author":"Dzaye","year":"2016","journal-title":"J Neuropathol Exp Neurol"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/noq082","article-title":"Glioma cancer stem cells induce immunosuppressive macrophages\/microglia","volume":"12","author":"Wu","year":"2010","journal-title":"Neuro-Oncol"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14112756","article-title":"The role of indoleamine 2, 3-dioxygenase 1 in regulating tumor microenvironment","volume":"14","author":"Huang","year":"2022","journal-title":"Cancers"},{"key":"B107","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1186\/s12974-021-02193-0","article-title":"Smek1 deficiency exacerbates experimental autoimmune encephalomyelitis by activating proinflammatory microglia and suppressing the IDO1-AhR pathway","volume":"18","author":"Duan","year":"2021","journal-title":"J Neuroinflamm"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1830872\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T05:34:37Z","timestamp":1781760877000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1830872\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,18]]},"references-count":107,"alternative-id":["10.3389\/fimmu.2026.1830872"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1830872","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,18]]},"article-number":"1830872"}}